We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Kala Pharmaceuticals Inc
43 own
58 watching
Current Price
$7.69
$0.01
(0.13%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
19.51M
52-Week High
8.79000
52-Week Low
4.21000
Average Volume
0.07M
Dividend Yield
--
P/E Ratio
--
Market Capitalization19.51M52-Week High8.7900052-Week Low4.21000Average Volume0.07MDividend Yield--P/E Ratio--What does the Kala Pharmaceuticals Inc do?
N/A
Read More
How much money does Kala Pharmaceuticals Inc make?
News & Events about Kala Pharmaceuticals Inc.
Globe Newswire
1 year ago
MENLO PARK, Calif. and ARLINGTON, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today ...
Globe Newswire
1 year ago
ARLINGTON, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that the U.S. Food ...
Globe Newswire
1 year ago
--No safety issues identified in Cohort 1 ---- Now proceeding to Cohort 2 to evaluate the safety and efficacy of two doses of KPI-012 in a multicenter, randomized, double-masked, vehicle-controlled trial ---- Topline data for Cohort 2 targeted for 1Q 2024; if positive, trial could potentially serve ...
PR Newswire
1 year ago
Thinking about buying stock in BridgeBio Pharma, Kala Pharmaceuticals, Azul, Unicycive Therapeutics, or Ciena Corp? Thinking about buying stock in BridgeBio Pharma, Kala Pharmaceuticals, Azul, Unicycive Therapeutics, or Ciena Corp? PR Newswire NEW YORK, March 6, 2023 NEW YORK, March 6, 2023...
Globe Newswire
1 year ago
-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million private placement financing, extending cash runway into 1Q 2025 -- ARLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (...
Frequently Asked Questions
Frequently Asked Questions
What is Kala Pharmaceuticals Inc share price today?
Can Indians buy Kala Pharmaceuticals Inc shares?
How can I buy Kala Pharmaceuticals Inc shares from India?
Can Fractional shares of Kala Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Kala Pharmaceuticals Inc stocks?
What is today’s traded volume of Kala Pharmaceuticals Inc?
What is today’s market capitalisation of Kala Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Kala Pharmaceuticals Inc?
What percentage is Kala Pharmaceuticals Inc down from its 52-Week High?
What percentage is Kala Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$7.69
$0.01
(0.13%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.